Stay updated on FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial

Sign up to get notified when there's something new on the FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3; this seems to be a small internal site update with no visible changes to study content.
    Difference
    0.0%
    Check dated 2026-03-06T18:33:07.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Gastric cancer added as a related topic/keyword and Genetic and Rare Diseases Information Center resources linked; the page revision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:41:49.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Revision label on the page updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T15:39:58.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page adds a 'Show glossary' option and updates QC metadata to 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while removing the older entries 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.1%
    Check dated 2026-01-29T09:22:30.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.3.4, replacing the previous Revision: v3.3.3.
    Difference
    0.0%
    Check dated 2026-01-15T02:41:17.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    New location entries were added for Florida, New York, Rio Grande do Norte, Region Met, Baden-Wurttemberg, Lower Saxony, and Saxony, while corresponding location entries were removed. The page revision was updated from v3.3.2 to v3.3.3.
    Difference
    0.5%
    Check dated 2025-12-24T11:29:18.000Z thumbnail image

Stay in the know with updates to FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FIDES-03 Derazantinib Combo in Gastric Adenocarcinoma Clinical Trial page.